Once-Weekly Retatrutide Reduces Weight and Knee Pain in Patients With Obesity and Osteoarthritis Kennedy Ferruggia, Associate Editor Ron Panarotti Key Takeaways Retatrutide, a triple hormone receptor agonist, achieved significant weight loss and pain improvement in individuals with obesity and knee osteoarthritis over 68 weeks
Are natural weight loss supplements for women different from those for men
What would move this position is: a randomised, placebo-controlled trial in a defined population with an objective primary endpoint, a pre-registered protocol, and pharmacovigilance over a clinically meaningful duration
However, in support of a causal relationship, lowering of HR by ivabradine, a selective inhibitor of the sinus node I(f) channel, devoid of any activity on blood pressure, cardiac contractility, atrioventricular conduction or ventricular repolarization, decreased the risk of cardiovascular death or hospitalization due to heart failure (HF) in subjects with HF, which is a debilitating condition highly sensitive to changes in HR [40]
ON THE PEN RESOURCES AND LINKS: What if the most powerful obesity drug ever created ends up being the one you cant get
Sleep Med